Breast Neoplasms: all 12,828 studies
Page 76 of 129. Open to participants first (2,932), then studies with results posted, then the rest; newest registration first within each.
- Implementing Patients´ Competence in Oral Breast Cancer TherapyStatus unknownNCT04030728
- Screening Magnetic Resonance Imaging of the Brain in Patients With Breast CancerActive, not recruitingNCT04030507Not applicable
- Effects of Computer-Assisted Cognitive Rehabilitation Programs With Breast Cancer SurvivorsStatus unknownNCT04027400Not applicable
- Randomized Clinical Trial Comparing Rehabilitation Robotic Versus Conventional After Breast Cancer SurgeryStatus unknownNCT04025112Not applicable
- Establishing the Recommended Biological Dose for AE37 Peptide Vaccine in Combination With Pembrolizumab That Will Enhance the Tumor-specific Immune Response and Demonstrate Efficacy in Patients With Advanced Triple-negative Breast CancerStatus unknownNCT04024800Phase 2
- Effects of a Physical Exercise Program in Quality of Life of Breast Cancer SurvivorsCompletedNCT04024280Not applicable
- Eurythmy Therapy (ERYT) as a Treatment Option for Fatigue in Metastatic Breast Cancer PatientsCompletedNCT04024267Not applicable
- Effect of PACK Health Support Program on Patient Reported Outcomes in Patients With Breast CancerCompletedNCT04022772Not applicable
- Using Clinicopathomic Markers to Predict Neoadjuvant Chemotherapy Response in Breast CancerStatus unknownNCT04021069
- Advanced MR Techniques for Breast Cancer DetectionWithdrawnNCT04020523Not applicable
- Psychometric Properties of the Updated Module on Assessing Quality of Life of Patients With Breast CancerCompletedNCT04018235
- EndoPredict® Extended Endocrine Trial (EXET)TerminatedNCT04016935
- Pilot Breast-Dedicated PET Camera With 1 Millimeter Spatial ResolutionWithdrawnNCT04016818Early Phase 1
- Hypofractionated Versus Conventional Fractionation RadiotherapyStatus unknownNCT04015531Not applicable
- Accessible Cancer Care to Enable Support for Survivors ProgrammeStatus unknownNCT04014309Not applicable
- Prevention of Female Cancers by Optimization of Selenium Levels in the Organism.Status unknownNCT04014283Not applicable
- Exercise Post-Diagnosis of Breast CancerCompletedNCT04013568Not applicable
- Capecitabine in Combination With Aromatase Inhibitor Versus Aromatase Inhibitors, in Hormonal Receptor Positive Recurrent or Metastatic Breast Cancer Patients, Randomized Controlled StudyStatus unknownNCT04012918Phase 2
- IMpact of Breast cAncer Gene Status on Survival in Adjuvant Breast Cancer (IMBASSA)CompletedNCT04012229
- Tw HER2 Positive Breast Cancer Productivity & Utility StudyStatus unknownNCT04011085
- Efficacy and Safety of 4.5mg PEG-rhG-CSF Per Cycle in Preventing Neutropenia After Intensive Chemotherapy for Breast CancerCompletedNCT04009941Phase 4
- Exploring the Link Between Cancer Genetics and PPSPStatus unknownNCT04007861
- Acupuncture Pilot Study for Cancer-related Cognitive FunctionActive, not recruitingNCT04007770Phase 2
- Brief Intervention for Tobacco and Alcohol Risk Reduction for Couple During Breast Cancer Treatment.WithdrawnNCT04007549Not applicable
- 18F-FES PET/CT's Additional Clinical Value in ER+ BCCompletedNCT04006626
- A Study Comparing Immunopheresis® Alone or In Combination With Chemotherapy Versus Chemotherapy Alone in Treatment of Advanced Breast Cancer PatientsStatus unknownNCT04004910Phase 1/2
- Deep Learning Algorithms for Prediction of Lymph Node Metastasis and Prognosis in Breast Cancer MRI Radiomics (RBC-01)Status unknownNCT04003558
- Comprehensive Genetic Assessment, Risk and Education in a Mammography PilotCompletedNCT04002986Not applicable
- Adjuvant Radiotherapy on Circulating Cells in Breast Cancer PatientsCompletedNCT04002570
- Anlotinib in Metastatic HER2 Negative Breast CancerCompletedNCT04002284Phase 2
- Feasibility Study: Yoga Educational ProjectCompletedNCT04001751Not applicable
- Dual Anti-HER2 Therapy (Lapatinib and Trastuzumab) Plus Chemotherapy in HER2-positive MBCCompletedNCT04001634
- Pyrotinib in Combination With Capecitabine in Patients With Trastuzumab-resistant HER2-positive Advanced Breast CancerStatus unknownNCT04001621Phase 2
- A Phase 1/2 Study of CYT-0851 in B-Cell Malignancies and Advanced Solid TumorsCompletedNCT03997968Phase 1/2
- A Study of Pyrotinib Plus Vinorelbine in Comparison With Treatment of Physician's Choice in Participants With HER2-positive Locally Advanced or Metastatic Breast CancerStatus unknownNCT03997539Phase 2
- Zinc-L-Carnosine Prevents Dysphagia in Breast Cancer Patients Undergoing Adjuvant RadiotherapyCompletedNCT03997188Phase 3
- Capivasertib+Paclitaxel as First Line Treatment for Patients With Locally Advanced or Metastatic TNBCActive, not recruitingNCT03997123Phase 3
- Plan to Thrive: Extending Cancer Survivorship Care Beyond the ClinicCompletedNCT03996031
- Breast Cancer Patient Engagement With Patient Reported Outcome Measure SurveyActive, not recruitingNCT03995082Not applicable
- Pegylated Liposomal Doxorubicin Plus Albumin-Bound Paclitaxel and Trastuzumab in HER-2 Positive Breast CancerStatus unknownNCT03994107Phase 1/2
- Study to Evaluate the Efficacy and Safety of CDK4/6 Inhibitor SHR6390 Combined With Pyrotinib in the Treatment of HER2-positive Advanced Breast CancerStatus unknownNCT03993964Phase 2
- Continuous Serrates Plane Block in Axillary DissectionCompletedNCT03992859Not applicable
- Breast Cancer Liquid Biopsy StratificationStatus unknownNCT03992521
- 99mTc-ADAPT6-based HER2 Imaging in Breast CancerCompletedNCT03991260
- An Investigational Surgical Procedure (Vascularized Lymph Node Transfer) in Reducing the Risk of Lymphedema in Patients With Breast Cancer Undergoing Breast ReconstructionActive, not recruitingNCT03990610Not applicable
- Infrared Imaging for Breast Cancer ModelingCompletedNCT03990012Not applicable
- Personalised Risk-based Breast Cancer Prevention and ScreeningStatus unknownNCT03989258Not applicable
- Study of Pembrolizumab in Metastatic HER2-negative Breast Cancer Patients With APOBEC3B MutationActive, not recruitingNCT03989089Phase 2
- A Study Of SIBP-01 Or CN-Trastuzumab Plus Docetaxel And Carboplatin In HER2 Positive Breast CancerCompletedNCT03989037Phase 3
- Magnetic Seed Localisation for Nonpalpable Breast LesionsCompletedNCT03988777
- A Study of Abemaciclib (LY2835219) in Participants With HR+, HER2- Advanced Breast CancerWithdrawnNCT03988114Phase 4
- A Study With Pembrolizumab in Combination With Dual Anti-HER2 Blockade With Trastuzumab and Pertuzumab in Early Breast Cancer Patients With Molecular HER2-enriched Intrinsic Subtype (Keyriched-1)CompletedNCT03988036Phase 2
- Paclitaxel Therapeutic Drug Monitoring in Cancer PatientsSuspendedNCT03987555
- A New Mindfulness Intervention Called Mindfulness Based Swinging Technique (MBST) for Women With Breast CancerCompletedNCT03985267Not applicable
- Mathematical Modeling to Predict Response to Neoadjuvant Chemotherapy in Breast CancerCompletedNCT03983538
- Study of ISB 1302 (CD3 Bispecific Ab) in HER2-positive Metastatic Breast CancerTerminatedNCT03983395Phase 1/2
- Pegylated Liposomal Doxorubicin or Epirubicin in Neoadjuvant or Adjuvant Chemotherapy for Breast Cancer.CompletedNCT03983096
- Combination Neoadjuvant Chemotherapy With or Without Apatinib for HER2 Negative Breast CancerActive, not recruitingNCT03982485Phase 2
- Epicutaneous Cryoimmunotherapy Combined With Pembrolizumab for Cutaneous Metastatic Breast CancerTerminatedNCT03982004Phase 1
- Management of Perioperative Anxiety by the Cardiac Coherence Technique Coupled With a Hypnosis SessionCompletedNCT03981731Not applicable
- Adipose-Induced Regeneration of Breast Skin to Treat Post-Mastectomy Radiation Injury in Breast Cancer PatientsWithdrawnNCT03981718Not applicable
- Assessment of Complete Pathologic Response After Neoadjuvant Chemotherapy for Breast CancerCompletedNCT03981705
- Study on Physical Activity's Relationship With Cancer and CognitionCompletedNCT03980626Not applicable
- A "Window Trial" on Curcumin for Invasive Breast Cancer Primary TumorsCompletedNCT03980509Phase 1
- The REACH Study: A Novel Values-Based Intervention to Increase Endocrine Therapy Adherence Among Breast Cancer SurvivorsCompletedNCT03980093Not applicable
- A Study of Evaluating The Effects Of Pyrotinib After Adjuvant Trastuzumab In Women With Early Stage Breast CancerActive, not recruitingNCT03980054Phase 3
- Evaluation of Pertuzumab-Trastuzumab and Taxane in the Standard Treatment of Metastatic Breast CancerStatus unknownNCT03979911
- Assessment of Breast Cancer-Related Arm LymphedemaStatus unknownNCT03978754
- Memory Perception Assessment in Central/Non-central Nervous System CancersCompletedNCT03975959Not applicable
- Evaluation of NeoNavia® Biopsy System in Axillary Lymph NodesCompletedNCT03975855
- Nurse AMIE: Addressing Metastatic Individuals EverydayCompletedNCT03975621Not applicable
- Analyses of Exosomes in the Cerebrospinal Fluid for Breast Cancer Patients With Suspicion of Leptomeningeal Metastasis.WithdrawnNCT03974204Not applicable
- Clinical Application of ctDNA in Early Screening of Breast CancerStatus unknownNCT03973034
- Effect of Mindful Eating on Weight Management in Breast Cancer SurvivorsCompletedNCT03972540Not applicable
- Mindful-life: Mindfulness Based Intervention vs Cognitive Behavioral Therapy in Patients With Breast CancerStatus unknownNCT03972020Not applicable
- Avelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Stage IV or Unresectable, Recurrent Triple Negative Breast CancerActive, not recruitingNCT03971409Phase 2
- Survival Benefits of Statins in Breast Cancer PatientsStatus unknownNCT03971019Phase 3
- Alpha Radiation Emitters Device for the Treatment of Newly Diagnosed Breast Carcinoma Patients With Distant MetastasesTerminatedNCT03970967Not applicable
- Functional MRI in Predicting Response to ChemotherapyStatus unknownNCT03969524
- Neoadjuvant Hormonal Therapy Plus Palbociclib in Operable, Hormone Sensitive and HER2-Negative Primary Breast CancerCompletedNCT03969121Phase 3
- A Study of SHR6390 in Combination With Letrozole or Anastrozole in Patients With HR Positive and HER2 Negative Advanced Breast CancerStatus unknownNCT03966898Phase 3
- Nurse-Driven Telephone Intervention in Improving Side Effects in Cancer Patients Undergoing ChemotherapyCompletedNCT03964896Not applicable
- TALAVE: Induction Talazoparib Followed by Combination of Talazoparib and Avelumab in Advanced Breast CancerActive, not recruitingNCT03964532Phase 1/2
- Evaluation of IPI-549 Combined With Front-line Treatments in Pts. With Triple-Negative Breast Cancer or Renal Cell CarcinomaActive, not recruitingNCT03961698Phase 2
- Cancer Activity and Lifestyle Measurement StudyActive, not recruitingNCT03961685
- Frequency and Presentations of Chronic Pain Following Breast Cancer Surgery: An Observational Study in a Tertiary Care Hospital of PakistanCompletedNCT03961269
- AKT Inhibitor, Ipatasertib, With Endocrine and CDK 4/6 Inhibitor for Patients With Metastatic Breast Cancer (TAKTIC)Active, not recruitingNCT03959891Phase 1
- Intravenous Chemotherapy and Plant-based Dietary SupplementsCompletedNCT03959618
- Paclitaxel Injection (Albumin-bound) for Neoadjuvant Treatment of Breast CancerStatus unknownNCT03959397Phase 2
- Testing a Culturally Adapted Telephone Genetic Counseling InterventionCompletedNCT03959267Not applicable
- Capecitabine and Radiotherapy in the Adjuvant Treatment of Resistant Breast CancerCompletedNCT03958721Phase 1
- Clinico-biological Data Collection Study of Metastatic Breast CancerActive, not recruitingNCT03958136Not applicable
- A Safety Study of SGN-CD47M in Patients With Solid TumorsTerminatedNCT03957096Phase 1
- Yoga for Aromatase Inhibitor-related Knee Pain Relief in Breast Cancer PatientsCompletedNCT03956875Not applicable
- A Phase IV Study to Collect Data on the Efficacy and Safety of RIBociclib in Older Women With BreastcancerCompletedNCT03956654
- VSMART (Video-Conference Stress Management and Relaxation Training for Older Women With Breast Cancer)CompletedNCT03955991Phase 4
- A Study of LY3295668 Erbumine in Participants With Breast Cancer That Has Spread to Other Parts of the BodyCompletedNCT03955939Phase 1
- Hyperthermia and Olaparib in Treating Breast Cancer Patients With Chest Wall RecurrencesTerminatedNCT03955640Phase 1
- Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer PatientsStatus unknownNCT03954197Not applicable
- B003 in Patients With HER2-positive Recurrent or Metastatic Breast CancerCompletedNCT03953833Phase 1